| abstract |
The present invention relates to the use of probiotics in nutritional compositions or medicaments for the prevention or treatment of intestinal neuromuscular abnormalities. Such abnormalities are associated with, for example, collicity in infants, general bowel pain or bowel discomfort. Specifically, the present invention relates to the prevention or treatment of intestinal neuromuscular abnormalities after infection. Probiotics can be administered in a live or dead state, and the supernatant of the fermentation medium can also be used directly to achieve the beneficial effects reported herein. |